Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Study confirms effective, less toxic treatment option for adults with Burkitt lymphoma
In a new study, an alternative treatment regimen that is less toxic than standard dose-intensive…
Scientists identify obscure protein responsible for advanced breast cancer
South Australian scientists have made a critical breakthrough, discovering how an obscure protein causes breast…
Dire shortage of BCG impacts treatment of bladder cancer patients
Leading Australian urologist Professor Dickon Hayne has been one of the many health professionals happy…
Chemo & CAM: Is initiation of chemo affected by complementary, alternative medicine use?
Women with early-stage breast cancer for whom chemotherapy was indicated and who used dietary supplements and multiple types of complementary…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.